106 related articles for article (PubMed ID: 2894547)
41. Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.
Robertson JF; Todd JH; Ellis IO; Elston CW; Blamey RW
BMJ; 1988 Aug 20-27; 297(6647):511-4. PubMed ID: 3139179
[TBL] [Abstract][Full Text] [Related]
42. [Bromocriptine in metastasizing breast cancer].
Schulz KD
Dtsch Med Wochenschr; 1979 May; 104(18):652. PubMed ID: 376262
[No Abstract] [Full Text] [Related]
43. Bromocriptine in severe cyclical breast pain.
Durning P; Sellwood RA
Br J Surg; 1982 May; 69(5):248-9. PubMed ID: 7042033
[No Abstract] [Full Text] [Related]
44. Adjuvant androgen treatment of operable breast cancer--a 20 year analysis.
Karydas I; Fentiman IS; Tong D; Bulbrook RD; Hayward JL
Eur J Surg Oncol; 1987 Apr; 13(2):113-7. PubMed ID: 3556591
[TBL] [Abstract][Full Text] [Related]
45. Influence of prolactin on serum androgens in normoprolactinaemic women.
Mudge TJ; Blight L; White GH; Judd SJ
Clin Reprod Fertil; 1983 Mar; 2(1):19-25. PubMed ID: 6227379
[TBL] [Abstract][Full Text] [Related]
46. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.
Griem KL; Henderson IC; Gelman R; Ascoli D; Silver B; Recht A; Goodman RL; Hellman S; Harris JR
J Clin Oncol; 1987 Oct; 5(10):1546-55. PubMed ID: 3309196
[TBL] [Abstract][Full Text] [Related]
47. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.
Veronesi U; Saccozzi R; Del Vecchio M; Banfi A; Clemente C; De Lena M; Gallus G; Greco M; Luini A; Marubini E; Muscolino G; Rilke F; Salvadori B; Zecchini A; Zucali R
N Engl J Med; 1981 Jul; 305(1):6-11. PubMed ID: 7015141
[TBL] [Abstract][Full Text] [Related]
48. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
Buzdar AU
Oncologist; 2003; 8(4):335-41. PubMed ID: 12897330
[TBL] [Abstract][Full Text] [Related]
49. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.
Walters AS; Hening WA; Kavey N; Chokroverty S; Gidro-Frank S
Ann Neurol; 1988 Sep; 24(3):455-8. PubMed ID: 3067654
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D
Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616
[TBL] [Abstract][Full Text] [Related]
51. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
[TBL] [Abstract][Full Text] [Related]
52. Flow cytometric detection of tumor metastases during urologic surgery.
Nusbaum NJ; Kester RR; Mooppan UM; Kim H
Urology; 1991 Feb; 37(2):151-5. PubMed ID: 1992584
[TBL] [Abstract][Full Text] [Related]
53. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
[TBL] [Abstract][Full Text] [Related]
54. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
[TBL] [Abstract][Full Text] [Related]
55. A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up.
Chakrabarti J; Kenny FS; Syed BM; Robertson JF; Blamey RW; Cheung KL
Crit Rev Oncol Hematol; 2011 Jun; 78(3):260-4. PubMed ID: 20447833
[TBL] [Abstract][Full Text] [Related]
56. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).
Hind D; Wyld L; Beverley CB; Reed MW
Cochrane Database Syst Rev; 2006 Jan; (1):CD004272. PubMed ID: 16437480
[TBL] [Abstract][Full Text] [Related]
57. Serum prolactin levels and their relationship to survival in women with operable breast cancer.
Wang DY; Stepniewska KA; Allen DS; Fentiman IS; Bulbrook RD; Kwa HG; De Stavola BL; Reed MJ
J Clin Epidemiol; 1995 Jul; 48(7):959-68. PubMed ID: 7782804
[TBL] [Abstract][Full Text] [Related]
58. Recurrent operable breast cancer following incomplete mastectomy.
Kinne DW; el Aziz Richi A; Chu FC; Robbins GF; Ashikari R
Clin Bull; 1977; 7(3):109-12. PubMed ID: 616801
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
60. Treatment of benign breast disease with bromocriptine.
Mussa A; Dogliotti L
J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
